European Psychiatry - Volume 33 - March 2016

559 / 812

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805 S555
Positive and Negative Syndrome Scale (PANSS); Global Assessment
of Functioning (GAF); Clinical Global Impression (CGI); designed
extensive questionnaire to elicit demographic data; inquiry about
drug compliance and Victimization Questionnaire.
Results Seventy patients of the studied sample were non-
victimized and 30 patients were victimized. Victimized patients
were significantly younger, living mainly in urban areas, had less
frequent history of bullying at school. There were exposed sig-
nificantly to higher frequency of family domestic violence and
childhood abuse. They scored higher for all subscales and in total
PANSS scores and they were less compliant on medication than did
their non-victimized counterparts.
Conclusion Studies of victimization of mentally ill did not draw
the attention of researchers and clinicians in Arab world. This study
proves that victimization is not uncommon among patients with
schizophrenia; clinicians should include assessment for victimiza-
tion of their patients as a routine work. The current study provides
preliminary data for clinicians and policymakers to consider strate-
gies to protect patients with various mental illnesses from being
victimized.
Disclosure of interest The author has not supplied his declaration
of competing interest.
EV643
Study of self-perceived health in a
clinical sample
A. Fernandez-Quintana ∗, M.D.C. García-Mahía
Clinical University Hospital of La Coru˜na, Psychiatry, La Coru˜na,
Spain
∗ Corresponding author.
Introduction The assessment of self-perceived health provides an
insightful clinical tool when it comes to addressing the subjective
perception of social functioning, mental and physical health.
Objective To analyze self-perceived health in patients treated in
a primary care clinic and its relationship with other clinical and
socio-demographic variables.
Methods A randomized sample of 130 patients, aged 18 years or
over, undergoing treatment in a primary care clinic was evaluated.
Patientswere interviewed following a self-perceivedhealth scale as
well as a scale for other clinical and socio-demographic variables.
Clinical records were reviewed for prior psychiatric and somatic
diagnoses.
Results Overall, the prevalence of somatic disorders in our sim-
ple was 92.3%, whilst psychiatric disorders were present in 23% of
patients. Only 6% of the sample reported their mental health to be
affected to some degree, while 67% declared their physical health
to be damaged. Forty-three percent of the sample follows pre-
scribed psychopharmacological treatment. Women showed lower
self-perceived health and reported more psychiatric symptoms in
accordance with higher actual prevalences of psychiatric disorders.
Among those patients with a psychiatric illness, only two reported
the will to search for mental health care, whilst most would prefer
consulting their general practitioner.
Conclusions Less than half of the patients who have been diag-
nosed with a psychiatric disorder consider their mental health to
be affected. Among those who do report a self-perceived mental
health concern, the majority would prefer consulting their general
practitioner rather than a psychiatrist.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV644
Motives and behaviors of medical
students (mis)using prescription
stimulants
G. Fond , F. Berna ∗, P. Domenech
1 Schizophrenia Expert Center Fondation Fondamental, Creteil, France
2 Hôpitaux Universitaires de Strasbourg, Inserm U1114, FMTS,
Fondation FondaMental, Psychiatry, Strasbourg cedex, France
3 Inserm U955, Translational Psychiatry team, Créteil, France
4 Paris Est University, DHU Pe-PSY, Pôle de Psychiatrie des Hôpitaux
Universitaires H.-Mondor & Spine Institute, CRICM, UPMC, Inserm
UMR S 975, CNRS UMR 7225, CHU Pitié-Salpêtrière, Brain & Spine
Institute, CRICM, UPMC, Inserm UMR S 975, CNRS UMR 7225, CHU
Pitié-Salpêtrière, Créteil, France
∗ Corresponding author.
Aims To estimate the prevalence of psychostimulant use in
French medical undergraduate and postgraduate students, asso-
ciated consumption behaviors and motives.
Design A population-based cross-sectional study using a self-
administered online survey.
Participants A total of 1718 French students and physicians
(mean age 26.84 ±7.19 years, 37.1% male).
Measurements Self-reported lifetime use, motives, socio-
demographic and academic features for other the counter (OTC),
medically prescribed (MPP), and Illicit (IP) psychostimulant users.
Findings Lifetime prevalence of psychostimulant use was 33%
(29.7% for OTC, 6.7% for MPP and 5.2% for IP). OTC con-
sumption mainly aimed at increasing wakefulness during com-
petitive exams preparation and internship. OTC consumption
was twice more frequent among users of other psychostim-
ulants (MPP and/or IP). Most of OTC consumers began their
consumption during exam preparation. Corticoids were the
most frequently consumed MPP (4.5%) before methylphenidate
and modafinil (1.5% and 0.8%, respectively). Unlike corticoids,
methylphenidate and modafinil prescriptions are tightly regulated
in France. Motives for MPP consumption were increased aca-
demic performance/concentration–memory and wakefulness. In
that respect, restrictions on methylphenidate and modafinil pre-
scriptions seem to be effective at limiting misuse. Corticoids were
mostly consumed by interns seeking for wakefulness. Overall, 5.2%
of the subjects consumed at least once IP, mostly cocaine and
amphetamine derivatives. They sought euphoria and/or novelty.
Conclusions Psychostimulant use is common among French
undergraduate students, interns and postgraduate physicians. The
type of drug used seems to depend mainly on product avail-
ability. Increased rates of corticoids consumption for wakefulness
purposes suggest another potential public health problem, as cor-
ticoids may have severe side effects.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV645
The assessment of social disability in
persons with a diagnosis of mental
disorder. Preliminary data
T.M. Gondek∗, A. Królicka , B. Misiak , A. Kiejna
Wroclaw Medical University, Department of Psychiatry, Wroclaw,
Poland
∗ Corresponding author.
Social disability in persons diagnosed with mental disorder is
one of the factors preventing them from achieving the broadly
definedwell-being, evenwhen appropriate and effective treatment
is applied. Improvement in the field of social disability is therefore
one of the main challenges for the mental health and social welfare